{"id":160868,"date":"2026-02-09T19:25:14","date_gmt":"2026-02-09T19:25:14","guid":{"rendered":"https:\/\/www.europesays.com\/se\/160868\/"},"modified":"2026-02-09T19:25:14","modified_gmt":"2026-02-09T19:25:14","slug":"kan-tabletterna-bli-novo-nordisks-raddning","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/160868\/","title":{"rendered":"Kan tabletterna bli Novo Nordisks r\u00e4ddning?"},"content":{"rendered":"<p>Det danska l\u00e4kemedelsbolaget f\u00f6r fetma och diabetes har fortsatt ner\u00e5t p\u00e5 b\u00f6rsen. Nu senast p\u00e5 grund av en mycket svag prognos f\u00f6r 2026. I takt med att estimaten skruvas ned ser v\u00e4\u2026<\/p>\n<p>NOVO NORDISK | NEUTRAL. Novo Nordisk \u00e4r en dansk l\u2026<\/p>\n<p>Omni \u00e4r politiskt obundna och oberoende. Vi str\u00e4var efter att ge fler perspektiv p\u00e5 nyheterna. Har du fr\u00e5gor eller synpunkter kring v\u00e5r rapportering? <a href=\"https:\/\/omniekonomi.se\/kan-tabletter-bli-novo-nordisks-raddning\/a\/mailto:eko@omni.se\" class=\"ArticleActions_contactLink__W2F1M\" rel=\"nofollow noopener\" target=\"_blank\">Kontakta redaktionen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Det danska l\u00e4kemedelsbolaget f\u00f6r fetma och diabetes har fortsatt ner\u00e5t p\u00e5 b\u00f6rsen. Nu senast p\u00e5 grund av en&hellip;\n","protected":false},"author":2,"featured_media":160869,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[2646,12860,3357,72,70,71,1254,538,2958,1206,103,34,467,31,33,32,30],"class_list":["post-160868","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-affarsvarlden","tag-aktieanalys","tag-aktierekar","tag-business","tag-economy","tag-ekonomi","tag-investeringar","tag-lakemedel-medicinteknik","tag-lakemedelsindustri","tag-novo-nordisk","tag-premium","tag-se","tag-stockholmsborsen","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116042316063764403","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/160868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=160868"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/160868\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/160869"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=160868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=160868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=160868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}